No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
285 |
4. Check minimum number of eventsNone |
285 |
5. Include endpointsNone |
285 |
6. Filter based on genotype QC (FinnGen only) |
285 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEXUAL_TRANSMISSION
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Trichomoniasis
based on the number of shared cases.
Similar with more cases:
- Infections with a predominantly sexual mode of transmission
- Certain infectious and parasitic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2807 | 2630 | 154 |
| Only index persons | 2299 | 2200 | 99 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.00 |
| Only index persons | 0.08 | 0.08 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 28.96 | 28.00 | 43.83 |
| Only index persons | 26.98 | 26.72 | 32.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 285 | 271 | 14 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.01 |
| Median age at first event (years) | 25.56 | 24.58 | 44.51 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 264
- Matched controls
- 2638
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
13199
ICD-8 Finland
Trichomoniasis urogenitalis, Unspecified
+∞
230.3
186
*
13197
ICD-8 Finland
Trichomoniasis urogenitalis, Suspecta
+∞
25.4
24
*
A59.0
ICD-10 Finland
Urogenital trichomoniasis
250.9
23.0
23
*
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
5.3
20.5
69
165
13100
ICD-8 Finland
NA
+∞
16.8
16
*
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
5.4
14.6
46
100
11299
ICD-8 Finland
Moniliasis
20.4
13.1
19
10
N05CD07
ATC
temazepam; oral
3.1
9.8
61
236
09801
ICD-8 Finland
Gonococcal infections, Urethritis acuta cum salpingo-cophoritide
+∞
9.4
9
*
N05AH04
ATC
quetiapine; oral
3.0
8.8
56
220
09808
ICD-8 Finland
Gonococcal infections, Uro-genitalis acuta, alia
+∞
8.4
8
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.6
8.2
23
44
61208
ICD-8 Finland
Acute salpingitis and oophoritis, Alia definita
17.9
8.1
12
7
A59.9
ICD-10 Finland
Trichomoniasis, unspecified
+∞
7.3
7
*
1310A
ICD-9 Finland
Trichomoniasis, Urogenital trichomoniasis
+∞
7.3
7
*
N05BA04
ATC
oxazepam; oral
2.2
7.1
86
475
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.8
7.0
29
84
62202
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Endometritis NUD
23.2
6.7
9
*
N07BA03
ATC
varenicline; oral
4.8
6.6
21
47
SPAT1254
SPAT
Administration of medicine
2.7
6.5
45
188
62200
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta
14.8
6.4
10
7
N05AA02
ATC
levomepromazine; systemic
4.8
6.4
20
44
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.2
6.4
16
27
61207
ICD-8 Finland
Acute salpingitis and oophoritis, suspecta
9.6
6.4
12
13
K05.31
ICD-10 Finland
Periodontitis pronounced
2.9
6.3
37
139
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
18.6
6.3
9
5
N06AB03
ATC
fluoxetine; oral
2.5
6.1
50
226
SPAT1263
SPAT
Sampling
1.9
6.1
122
815
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
124
3.08
7.86
3.7
3.1
2.1
1.8
mmol/l
0.23
26
98
166
1197
1.93
6.73
5.7
4.8
1.2
1.2
mmol/l
0.15
137
1070
69
366
2.17
6.71
4.9
4.6
31.6
33.6
%
0.87
44
223
83
476
2.05
6.57
2.1
1.7
1106.2
1266.9
nmol/l
0.81
51
345
173
1301
1.84
5.78
7.5
5.5
1.2
1.2
mmol/l
0.66
127
1090
185
1421
1.86
5.77
6.1
4.2
6.8
6.6
mmol/l
0.55
174
1324
112
802
1.65
3.99
2.6
2.3
48.9
56.8
u/l
1.85
100
716
185
1504
1.66
3.94
4.2
2.9
52.2
47.8
u/l
0.32
160
1364
22
92
2.51
3.66
3.0
1.9
—
—
—
0
0
21
86
2.56
3.64
3.0
1.9
—
—
—
0
0
29
142
2.16
3.40
3.7
3.0
4.1
4.5
pmol/l
1.48
29
121
103
746
1.60
3.40
3.1
2.7
2220.5
1027.4
ng/l
0.95
82
632
169
1377
1.56
3.29
6.1
5.8
8.8
10.0
umol/l
2.28
150
1288
45
264
1.84
3.20
5.5
3.5
—
—
—
0
0
51
311
1.78
3.20
2.5
2.1
22.5
22.1
%
0.10
40
264
123
948
1.52
3.00
5.3
3.5
47.7
65.1
ng/l
0.18
92
685
54
349
1.68
2.76
2.7
2.1
12.5
13.2
umol/l
0.33
48
320
50
324
1.66
2.53
2.7
2.1
2.3
2.4
g/l
0.41
44
297
16
71
2.33
2.39
3.5
2.2
—
—
—
0
0
12
46
2.68
2.39
1.5
1.2
—
—
—
0
0
80
587
1.50
2.38
1.8
1.5
20.5
22.5
nmol/l
0.45
63
486
7
18
3.96
2.26
1.4
1.4
14.5
17.4
ug/l
—
7
18
55
376
1.57
2.24
2.1
1.9
—
—
—
0
0
77
568
1.49
2.22
3.2
2.1
2.8
3.2
mg/l
0.86
63
481
20
101
2.05
2.21
3.0
1.5
—
—
—
0
0
81
605
1.47
2.19
2.4
2.2
—
—
—
0
0
106
837
1.42
2.13
3.7
3.2
—
—
—
0
0
11
43
2.62
2.12
3.1
1.7
—
—
—
0
0
74
547
1.48
2.10
1.8
1.7
465.9
14747014.5
pmol/l
0.50
53
434
168
1440
1.41
2.09
7.8
9.3
4.4
3.8
e9/l
1.96
144
1268
13
56
2.38
2.08
1.2
1.6
—
—
—
0
0
6
15
4.06
2.05
1.2
1.3
—
—
—
0
0
135
1118
1.39
2.05
4.9
3.8
35.0
35.7
g/l
0.81
117
1038
89
686
1.43
2.03
5.0
4.5
0.0
0.0
estimate
0.00
37
231
36
228
1.66
2.00
4.1
3.5
1.2
1.2
mmol/l
0.31
26
194
140
1174
1.38
1.94
4.4
3.7
—
—
—
0
0
35
228
1.61
1.75
3.1
1.9
0.2
0.2
g/l
0.81
30
215
126
1057
1.34
1.67
2.2
1.9
109.1
98.1
pmol/l
1.09
62
466
17
91
1.92
1.64
2.8
1.4
—
—
—
0
0
8
33
2.46
1.55
1.1
1.0
—
—
—
0
0
8
33
2.46
1.55
3.4
1.5
—
—
—
0
0
81
642
1.37
1.53
3.3
3.1
0.7
0.5
e6/l
0.30
63
460
223
2055
1.39
1.50
5.3
4.4
15.0
15.0
pmol/l
0.04
188
1846
39
542
0.68
1.48
1.6
1.4
—
—
—
0
0
135
1159
1.31
1.48
2.6
2.2
78.1
79.1
nmol/l
0.15
113
1013
11
53
2.12
1.40
1.2
1.7
—
—
—
0
0
5
17
2.97
1.36
1.0
1.3
—
—
—
0
0
5
17
2.97
1.36
1.6
1.5
—
—
—
0
0
13
230
0.54
1.34
2.6
2.6
69.2
64.4
ml/min/173m2
—
6
89
140
1220
1.29
1.33
4.5
4.0
0.0
0.0
estimate
0.00
39
230
214
1976
1.33
1.29
8.6
7.2
77.8
78.7
u/l
0.13
195
1814
9
44
2.08
1.28
1.2
1.4
—
—
—
0
0
73
585
1.33
1.28
1.2
1.2
0.9
1.3
u/ml
0.42
21
156
8
36
2.26
1.25
1.1
1.4
—
—
—
0
0
8
36
2.26
1.25
1.1
1.4
—
—
—
0
0
8
36
2.26
1.25
1.1
1.4
—
—
—
0
0
115
985
1.28
1.23
3.6
2.6
114.7
105.3
ug/l
0.28
98
889
142
1249
1.27
1.22
4.5
4.0
0.0
0.0
estimate
0.00
38
224
12
64
1.91
1.20
1.1
1.2
—
—
—
0
0
6
26
2.33
1.19
1.0
1.0
—
—
—
0
0
70
565
1.32
1.16
1.5
1.6
0.8
1.0
mg/l
0.46
55
439
12
65
1.88
1.15
3.3
1.5
—
—
—
0
0
140
1238
1.26
1.13
5.8
5.2
0.0
0.0
estimate
0.00
40
227
20
129
1.59
1.09
1.3
1.3
—
—
—
0
0
7
33
2.15
1.06
1.1
1.4
—
—
—
0
0
7
34
2.08
1.03
1.1
1.4
—
—
—
0
0
7
34
2.08
1.03
1.3
1.4
—
—
—
0
0
7
34
2.08
1.03
1.1
1.4
—
—
—
0
0
205
1905
1.27
1.03
5.0
4.5
15.8
13.5
mm/h
1.23
175
1724
9
48
1.90
1.01
1.3
1.3
—
—
—
0
0
93
793
1.26
1.00
2.0
2.2
118.8
156.5
u/l
0.93
80
745
9
49
1.86
0.99
1.1
1.3
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
13
77
1.72
0.97
1.1
1.2
—
—
—
0
0
247
2362
1.34
0.92
6.5
5.3
2.0
2.4
mu/l
0.39
210
2128
9
156
0.56
0.91
1.4
1.8
—
—
—
0
0
45
356
1.31
0.87
4.9
6.0
—
—
—
0
0
8
44
1.84
0.86
1.1
1.1
—
—
—
0
0
13
80
1.65
0.86
1.4
4.3
31.6
34.5
mg/l
—
8
62
13
80
1.65
0.86
1.4
4.3
29.0
22.9
mg/l
—
8
62
107
941
1.22
0.86
2.4
3.5
2.4
2.4
mmol/l
0.32
82
821
106
933
1.22
0.84
5.0
4.2
—
—
—
0
0
10
59
1.72
0.77
1.2
1.3
—
—
—
0
0
23
167
1.41
0.76
1.6
1.5
—
—
—
0
0
5
24
2.10
0.75
1.8
2.2
—
—
—
0
0
5
25
2.02
0.73
1.6
2.1
1.0
3.2
nmol/l
—
5
25
7
39
1.81
0.73
1.3
1.6
—
—
—
0
0
254
2458
1.31
0.69
19.3
13.3
22.7
20.5
mg/l
0.48
209
1892
16
111
1.47
0.67
6.5
7.1
24.9
24.8
mmol/l
0.01
16
102
7
43
1.64
0.67
1.3
1.7
—
—
—
0
0
87
770
1.19
0.64
3.8
2.9
29.6
29.8
u/l
0.02
75
728
19
140
1.38
0.60
1.8
1.7
—
—
—
0
0
6
36
1.68
0.57
1.2
1.1
14.5
39.6
u/l
—
6
29
244
2362
1.23
0.56
7.1
6.0
40.6
39.7
mmol/mol
0.97
208
2155
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
206
2146
0.86
0.53
18.0
14.4
38.7
39.3
%
0.42
100
1415
37
310
1.22
0.49
2.8
4.0
4.5
7.9
ug/l
1.05
28
263
255
2487
1.24
0.49
5.5
4.9
6.1
5.9
mmol/l
1.05
210
2240
265
2596
1.30
0.48
21.6
15.3
139.5
139.9
mmol/l
1.64
251
2512
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
5
33
1.52
0.41
1.8
1.4
4.5
119.7
u/ml
—
5
33
0
15
0.00
0.41
0.0
1.4
—
2.7
—
0
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
29
242
1.22
0.41
5.1
2.3
4.3
7.2
umol/l
1.77
21
207
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
12
88
1.38
0.40
1.8
1.6
1.1
1.2
g/l
0.50
12
83
13
97
1.36
0.40
1.1
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
1.2
—
0
10
265
2603
1.26
0.40
21.8
15.3
4.0
3.9
mmol/l
0.07
250
2511
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
252
2465
1.19
0.39
5.0
4.8
4.8
4.9
mmol/l
0.55
213
2240
6
88
0.68
0.33
1.3
3.7
28.8
25.1
u/ml
—
6
88
6
89
0.67
0.33
1.2
1.2
—
—
—
0
0
6
90
0.66
0.33
1.2
1.2
—
—
—
0
0
7
54
1.30
0.30
1.6
1.7
—
—
—
0
0
136
1296
1.09
0.29
2.7
2.4
—
—
—
0
0
31
270
1.17
0.29
1.7
1.8
—
—
—
0
0
241
2362
1.13
0.28
4.6
4.2
1.4
1.3
mmol/l
1.33
198
2121
20
235
0.84
0.27
3.3
2.1
33.1
32.9
u/l
0.01
15
195
5
71
0.70
0.26
1.2
1.6
—
—
—
0
0
10
127
0.78
0.26
1.7
1.4
—
—
—
0
0
5
38
1.32
0.23
1.4
1.8
—
—
—
0
0
20
173
1.17
0.21
4.0
3.1
334.6
161.6
ng/l
0.70
20
161
8
103
0.77
0.21
1.4
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
65
608
1.09
0.21
2.5
2.5
333.2
9394.9
umol/l
3.88
52
504
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
24
213
1.14
0.19
9.1
6.5
117.3
118.9
g/l
0.17
24
208
30
271
1.12
0.19
1.8
1.9
—
—
—
0
0
14
119
1.19
0.18
1.6
1.3
—
—
—
0
0
248
2450
1.09
0.16
5.3
4.8
1.6
1.6
mmol/l
1.37
208
2219
78
746
1.06
0.15
1.6
1.6
1.4
1.3
mmol/l
0.33
58
613
33
306
1.09
0.13
24.9
18.2
1.0
1.2
inr
—
6
50
11
125
0.88
0.10
4.9
2.7
0.1
0.2
e6/l
0.21
11
118
37
391
0.94
0.10
1.6
1.4
—
—
—
0
0
19
174
1.10
0.09
1.3
1.2
87.2
138.5
iu/ml
—
7
72
5
48
1.04
0.09
1.2
1.4
—
—
—
0
0
5
48
1.04
0.09
1.2
1.4
—
—
—
0
0
15
136
1.11
0.08
1.0
1.0
—
—
—
0
0
10
113
0.88
0.08
3.0
2.1
0.8
0.7
%
—
10
108
39
409
0.95
0.08
2.7
2.6
1.4
1.2
e6/l
0.12
22
223
5
60
0.83
0.08
1.6
1.4
—
—
—
0
0
5
60
0.83
0.08
1.2
1.1
2.8
4.0
mmol/l
—
5
55
5
60
0.83
0.08
1.2
1.2
21977.8
79.1
e6/l
—
5
50
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
46
442
1.05
0.07
5.1
3.8
53.5
190.4
ng/l
1.54
32
349
35
367
0.95
0.07
2.8
2.8
5.0
4.2
e6/l
0.19
18
183
48
498
0.96
0.07
1.3
1.3
33.8
33.8
iu/ml
0.00
13
159
9
87
1.04
0.07
1.2
1.5
—
—
—
0
0
16
173
0.92
0.07
3.4
2.2
4.2
4.2
kpa
0.11
16
168
8
95
0.84
0.07
9.9
3.1
22.8
25.1
mmol/l
—
8
84
271
2700
1.08
0.04
28.2
20.4
129.5
132.4
g/l
2.86
259
2649
48
491
0.97
0.03
1.2
1.3
18.8
12.4
u/ml
0.16
12
185
10
106
0.94
0.01
1.3
1.7
—
—
—
0
0
236
2366
0.99
0.00
17.4
12.8
79.2
77.4
ml/min/173m2
0.66
194
1893
52
522
1.00
0.00
2.5
2.8
2.5
2.5
mmol/l
1.44
46
467
252
2523
0.99
0.00
5.7
5.4
2.7
2.8
mmol/l
1.16
216
2277
263
2625
1.02
0.00
12.8
10.9
23.7
23.7
u/l
0.00
240
2510
6
63
0.95
0.00
1.7
1.8
—
—
—
0
0
6
68
0.88
0.00
1.2
1.1
512.0
484.2
mg/l
—
6
63
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
5.0
—
214.9
—
0
7
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
1750.3
—
0
8
0
6
0.00
0.00
0.0
1.3
—
150.7
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
108.8
—
0
5
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
10.1
—
0
9
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
41.1
—
0
9
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
12.2
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TRICHOMONIASIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_TRICHOMONIASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_TRICHOMONIASIS – Trichomoniasis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data